BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gavriilaki E, Brodsky RA. Severe COVID‐19 infection and thrombotic microangiopathy: success does not come easily. Br J Haematol 2020;189. [DOI: 10.1111/bjh.16783] [Cited by in Crossref: 95] [Cited by in F6Publishing: 84] [Article Influence: 47.5] [Reference Citation Analysis]
Number Citing Articles
1 Rojas A, Lindner C, Gonzàlez I, Morales MA. Advanced-glycation end-products axis: A contributor to the risk of severe illness from COVID-19 in diabetes patients. World J Diabetes 2021;12:590-602. [PMID: 33995847 DOI: 10.4239/wjd.v12.i5.590] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Muhanna D, Arnipalli SR, Kumar SB, Ziouzenkova O. Osmotic Adaptation by Na+-Dependent Transporters and ACE2: Correlation with Hemostatic Crisis in COVID-19. Biomedicines 2020;8:E460. [PMID: 33142989 DOI: 10.3390/biomedicines8110460] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
3 Lakshmanan HHS, Pore AA, Kohs TCL, Yazar F, Thompson RM, Jurney PL, Maddala J, Olson SR, Shatzel JJ, Vanapalli SA, McCarty OJT. Design of a Microfluidic Bleeding Chip to Evaluate Antithrombotic Agents for Use in COVID-19 Patients. Cell Mol Bioeng 2020;:1-9. [PMID: 32837586 DOI: 10.1007/s12195-020-00644-x] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Gavriilaki M, Kimiskidis VK, Gavriilaki E. Precision Medicine in Neurology: The Inspirational Paradigm of Complement Therapeutics. Pharmaceuticals (Basel) 2020;13:E341. [PMID: 33114553 DOI: 10.3390/ph13110341] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Al-Kuraishy HM, Al-Gareeb AI, Al-Hussaniy HA, Al-Harcan NAH, Alexiou A, Batiha GE. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality. Int Immunopharmacol 2022;104:108516. [PMID: 35032828 DOI: 10.1016/j.intimp.2021.108516] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
6 Cacciapuoti F, Cacciapuoti F. Could Low Doses Acetylsalicylic Acid Prevent Thrombotic Complications in COVID-19 Patients? Clin Appl Thromb Hemost 2021;27:10760296211014592. [PMID: 33928791 DOI: 10.1177/10760296211014592] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Gavriilaki E, Ho VT, Schwaeble W, Dudler T, Daha M, Fujita T, Jodele S. Role of the lectin pathway of complement in hematopoietic stem cell transplantation-associated endothelial injury and thrombotic microangiopathy. Exp Hematol Oncol 2021;10:57. [PMID: 34924021 DOI: 10.1186/s40164-021-00249-8] [Reference Citation Analysis]
8 Gavriilaki E, Eftychidis I, Papassotiriou I. Update on endothelial dysfunction in COVID-19: severe disease, long COVID-19 and pediatric characteristics. Journal of Laboratory Medicine 2021;45:293-302. [DOI: 10.1515/labmed-2021-0134] [Reference Citation Analysis]
9 Lockhart SM, O'Rahilly S. When Two Pandemics Meet: Why Is Obesity Associated with Increased COVID-19 Mortality? Med (N Y) 2020;1:33-42. [PMID: 32838359 DOI: 10.1016/j.medj.2020.06.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
10 Al-hakeim HK, Al-hamami SA, Almulla AF, Maes M. Increased Serum Thromboxane A2 and Prostacyclin but Lower Complement C3 and C4 Levels in COVID-19: Associations with Chest CT Scan Anomalies and Lowered Peripheral Oxygen Saturation. COVID 2021;1:489-502. [DOI: 10.3390/covid1020042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
11 Esmaeilzadeh A, Rostami S, Yeganeh PM, Tahmasebi S, Ahmadi M. Recent advances in antibody-based immunotherapy strategies for COVID-19. J Cell Biochem 2021. [PMID: 34160093 DOI: 10.1002/jcb.30017] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Chang JC. COVID-19 Sepsis: Pathogenesis and Endothelial Molecular Mechanisms Based on "Two-Path Unifying Theory" of Hemostasis and Endotheliopathy-Associated Vascular Microthrombotic Disease, and Proposed Therapeutic Approach with Antimicrothrombotic Therapy. Vasc Health Risk Manag 2021;17:273-98. [PMID: 34103921 DOI: 10.2147/VHRM.S299357] [Reference Citation Analysis]
13 Fernández-Pérez GC, Oñate Miranda M, Fernández-Rodríguez P, Velasco Casares M, Corral de la Calle M, Franco López Á, Díez Blanco M, Cuchat JMO. SARS-CoV-2: what it is, how it acts, and how it manifests in imaging studies. Radiologia (Engl Ed) 2021;63:115-26. [PMID: 33309398 DOI: 10.1016/j.rx.2020.10.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Shalaby R, Adu MK, Andreychuk T, Eboreime E, Gusnowski A, Vuong W, Surood S, Greenshaw AJ, Agyapong VIO. Prevalence, Demographic, and Clinical Correlates of Likely PTSD in Subscribers of Text4Hope during the COVID-19 Pandemic. Int J Environ Res Public Health 2021;18:6227. [PMID: 34207537 DOI: 10.3390/ijerph18126227] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Gavriilaki E, Sakellari I, Gavriilaki M, Anagnostopoulos A. A New Era in Endothelial Injury Syndromes: Toxicity of CAR-T Cells and the Role of Immunity. Int J Mol Sci 2020;21:E3886. [PMID: 32485958 DOI: 10.3390/ijms21113886] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
16 McGonagle D, Bridgewood C, Ramanan AV, Meaney JFM, Watad A. COVID-19 vasculitis and novel vasculitis mimics. Lancet Rheumatol 2021;3:e224-33. [PMID: 33521655 DOI: 10.1016/S2665-9913(20)30420-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 22.0] [Reference Citation Analysis]
17 Diorio C, McNerney KO, Lambert M, Paessler M, Anderson EM, Henrickson SE, Chase J, Liebling EJ, Burudpakdee C, Lee JH, Balamuth FB, Blatz AM, Chiotos K, Fitzgerald JC, Giglia TM, Gollomp K, Odom John AR, Jasen C, Leng T, Petrosa W, Vella LA, Witmer C, Sullivan KE, Laskin BL, Hensley SE, Bassiri H, Behrens EM, Teachey DT. Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations. Blood Adv 2020;4:6051-63. [PMID: 33290544 DOI: 10.1182/bloodadvances.2020003471] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 14.5] [Reference Citation Analysis]
18 Varelas C, Tampaki A, Sakellari I, Anagnostopoulos Α, Gavriilaki E, Vlachaki E. Complement in Sickle Cell Disease: Are We Ready for Prime Time? J Blood Med 2021;12:177-87. [PMID: 33790681 DOI: 10.2147/JBM.S287301] [Reference Citation Analysis]
19 Gandhi B, Jebakumar D, Nickell M, Narayanan M. Thrombotic microangiopathy with multiorgan involvement following COVID-19. Baylor University Medical Center Proceedings 2022;35:204-6. [DOI: 10.1080/08998280.2021.1997054] [Reference Citation Analysis]
20 Rani I, Goyal A, Bhatnagar M, Manhas S, Goel P, Pal A, Prasad R. Potential molecular mechanisms of zinc- and copper-mediated antiviral activity on COVID-19. Nutr Res 2021;92:109-28. [PMID: 34284268 DOI: 10.1016/j.nutres.2021.05.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Turan O, Hakim A, Dashraath P, Jeslyn WJL, Wright A, Abdul-Kadir R. Clinical characteristics, prognostic factors, and maternal and neonatal outcomes of SARS-CoV-2 infection among hospitalized pregnant women: A systematic review. Int J Gynaecol Obstet 2020;151:7-16. [PMID: 32816307 DOI: 10.1002/ijgo.13329] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 20.5] [Reference Citation Analysis]
22 Bertoli F, Veritti D, Danese C, Samassa F, Sarao V, Rassu N, Gambato T, Lanzetta P. Ocular Findings in COVID-19 Patients: A Review of Direct Manifestations and Indirect Effects on the Eye. J Ophthalmol 2020;2020:4827304. [PMID: 32963819 DOI: 10.1155/2020/4827304] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
23 Varghese PM, Tsolaki AG, Yasmin H, Shastri A, Ferluga J, Vatish M, Madan T, Kishore U. Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies. Immunobiology 2020;225:152008. [PMID: 33130519 DOI: 10.1016/j.imbio.2020.152008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
24 Cennamo G, Reibaldi M, Montorio D, D'Andrea L, Fallico M, Triassi M. Optical Coherence Tomography Angiography Features in Post-COVID-19 Pneumonia Patients: A Pilot Study. Am J Ophthalmol 2021;227:182-90. [PMID: 33781767 DOI: 10.1016/j.ajo.2021.03.015] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 22.0] [Reference Citation Analysis]
25 Oi SSP, Muniz MPR, Faria IM, Filho NS, de Brito DJA, Lages JS, Lauande LP, Oliveira TKM, Cunha KA, Neves PDMM, Silva GEB. Multisystemic Inflammatory Syndrome and Thrombotic Microangiopathy as Complications of COVID-19 in a Child: A Case Report. Front Pediatr 2021;9:659069. [PMID: 34150685 DOI: 10.3389/fped.2021.659069] [Reference Citation Analysis]
26 Page EM, Ariëns RAS. Mechanisms of thrombosis and cardiovascular complications in COVID-19. Thromb Res 2021;200:1-8. [PMID: 33493983 DOI: 10.1016/j.thromres.2021.01.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
27 Lund Berven L, Selvakumar J, Havdal L, Stiansen-Sonerud T, Einvik G, Leegaard TM, Tjade T, Michelsen AE, Mollnes TE, Wyller VBB. Inflammatory Markers, Pulmonary Function, and Clinical Symptoms in Acute COVID-19 Among Non-Hospitalized Adolescents and Young Adults. Front Immunol 2022;13:837288. [PMID: 35222429 DOI: 10.3389/fimmu.2022.837288] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Maiuolo J, Mollace R, Gliozzi M, Musolino V, Carresi C, Paone S, Scicchitano M, Macrì R, Nucera S, Bosco F, Scarano F, Zito MC, Ruga S, Tavernese A, Mollace V. The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection. Int J Mol Sci 2020;21:E9309. [PMID: 33291346 DOI: 10.3390/ijms21239309] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
29 Akilesh S, Nast CC, Yamashita M, Henriksen K, Charu V, Troxell ML, Kambham N, Bracamonte E, Houghton D, Ahmed NI, Chong CC, Thajudeen B, Rehman S, Khoury F, Zuckerman JE, Gitomer J, Raguram PC, Mujeeb S, Schwarze U, Shannon MB, De Castro I, Alpers CE, Najafian B, Nicosia RF, Andeen NK, Smith KD. Multicenter Clinicopathologic Correlation of Kidney Biopsies Performed in COVID-19 Patients Presenting With Acute Kidney Injury or Proteinuria. Am J Kidney Dis 2021;77:82-93.e1. [PMID: 33045255 DOI: 10.1053/j.ajkd.2020.10.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 33] [Article Influence: 11.5] [Reference Citation Analysis]
30 Duque P, Chasco-Ganuza M, Burgos-Santamaria A, Terradillos E. Increased resistance to fibrinolysis activation in patients with coronavirus disease 2019: a case series. Blood Coagul Fibrinolysis 2021;32:298-301. [PMID: 33491994 DOI: 10.1097/MBC.0000000000001017] [Reference Citation Analysis]
31 Stoeckle K, Witting B, Kapadia S, An A, Marks K. Elevated inflammatory markers are associated with poor outcomes in COVID-19 patients treated with remdesivir. J Med Virol 2022;94:384-7. [PMID: 34406670 DOI: 10.1002/jmv.27280] [Reference Citation Analysis]
32 Piedrafita A, Ribes D, Cointault O, Chauveau D, Faguer S, Huart A. Plasma exchange and thrombotic microangiopathies: From pathophysiology to clinical practice. Transfus Apher Sci 2020;59:102990. [PMID: 33272850 DOI: 10.1016/j.transci.2020.102990] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Battina HL, Alentado VJ, Srour EF, Moliterno AR, Kacena MA. Interaction of the inflammatory response and megakaryocytes in COVID-19 infection. Exp Hematol 2021:S0301-472X(21)00328-3. [PMID: 34563606 DOI: 10.1016/j.exphem.2021.09.005] [Reference Citation Analysis]
34 Wessels I, Rolles B, Rink L. The Potential Impact of Zinc Supplementation on COVID-19 Pathogenesis. Front Immunol 2020;11:1712. [PMID: 32754164 DOI: 10.3389/fimmu.2020.01712] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 34.0] [Reference Citation Analysis]
35 Ullah I, Sohail A, Shah MUFA, Khurshid M, Diwan MN, Qadir A, Irfan M. Central Retinal Vein Occlusion in patients with COVID-19 infection: A systematic review. Ann Med Surg (Lond) 2021;71:102898. [PMID: 34659743 DOI: 10.1016/j.amsu.2021.102898] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Jamaly S, Tsokos MG, Bhargava R, Brook OR, Hecht JL, Abdi R, Moulton VR, Satyam A, Tsokos GC. Complement activation and increased expression of Syk, mucin-1 and CaMK4 in kidneys of patients with COVID-19. Clin Immunol 2021;229:108795. [PMID: 34252574 DOI: 10.1016/j.clim.2021.108795] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Mastellos DC, Pires da Silva BGP, Fonseca BAL, Fonseca NP, Auxiliadora-Martins M, Mastaglio S, Ruggeri A, Sironi M, Radermacher P, Chrysanthopoulou A, Skendros P, Ritis K, Manfra I, Iacobelli S, Huber-Lang M, Nilsson B, Yancopoulou D, Connolly ES, Garlanda C, Ciceri F, Risitano AM, Calado RT, Lambris JD. Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy. Clin Immunol 2020;220:108598. [PMID: 32961333 DOI: 10.1016/j.clim.2020.108598] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 34.0] [Reference Citation Analysis]
38 O'Donovan C, Vyas N, Ghanchi F. Retinal Vein Occlusion with COVID-19: A Case Report and Review of Literature. Ocul Immunol Inflamm 2022;:1-5. [PMID: 35119981 DOI: 10.1080/09273948.2022.2032196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Galanis N, Stavraka C, Agathangelidis F, Petsatodis E, Giankoulof C, Givissis P. Coagulopathy in COVID-19 infection: a case of acute upper limb ischemia. J Surg Case Rep. 2020;2020:rjaa204. [PMID: 32661487 DOI: 10.1093/jscr/rjaa204] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
40 Rokohl AC, Grajewski RS, Matos PAW, Kopecky A, Heindl LM, Cursiefen C. Ocular Involvement in COVID-19: Conjunctivitis and More. Klin Monbl Augenheilkd 2021;238:555-60. [PMID: 34020483 DOI: 10.1055/a-1344-8138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
41 Olszewska-Parasiewicz J, Szarpak Ł, Rogula S, Gąsecka A, Szymańska U, Kwiatkowska M, Jaguszewski MJ, Sierpiński R, Zaczyński A, Wierzba W, Kosior DA. Statins in COVID-19 Therapy. Life (Basel) 2021;11:565. [PMID: 34208435 DOI: 10.3390/life11060565] [Reference Citation Analysis]
42 Dalkıran T, Kandur Y, Kara EM, Dağoğlu B, Taner S, Öncü D. Thrombotic Microangiopathy in a Severe Pediatric Case of COVID-19. Clin Med Insights Pediatr 2021;15:11795565211049897. [PMID: 34707424 DOI: 10.1177/11795565211049897] [Reference Citation Analysis]
43 Verhoef PA, Kannan S, Sturgill JL, Tucker EW, Morris PE, Miller AC, Sexton TR, Koyner JL, Hejal R, Brakenridge SC, Moldawer LL, Hotchkiss RS, Blood TM, Mazer MB, Bolesta S, Alexander SA, Armaignac DL, Shein SL, Jones C, Hoemann CD, Doctor A, Friess SH, Parker RI, Rotta AT, Remy KE. Severe Acute Respiratory Syndrome-Associated Coronavirus 2 Infection and Organ Dysfunction in the ICU: Opportunities for Translational Research. Crit Care Explor 2021;3:e0374. [PMID: 33786450 DOI: 10.1097/CCE.0000000000000374] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
44 Gavriilaki E, Sakellari I, Gavriilaki M, Anagnostopoulos A. Thrombocytopenia in COVID-19: pathophysiology matters. Ann Hematol 2021;100:2139-40. [PMID: 32683455 DOI: 10.1007/s00277-020-04183-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Venkatesh R, Reddy NG, Agrawal S, Pereira A. COVID-19-associated central retinal vein occlusion treated with oral aspirin. BMJ Case Rep 2021;14:e242987. [PMID: 34011649 DOI: 10.1136/bcr-2021-242987] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Yu J, Yuan X, Chen H, Chaturvedi S, Braunstein EM, Brodsky RA. Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition. Blood 2020;136:2080-9. [PMID: 32877502 DOI: 10.1182/blood.2020008248] [Cited by in Crossref: 80] [Cited by in F6Publishing: 75] [Article Influence: 40.0] [Reference Citation Analysis]
47 Otieno SB, Altahan A, Kaweeta F, Karri S, Alnoor F, Johnson R. Severe Hemolysis in a COVID-19 Patient with Paroxysmal Nocturnal Hemoglobinuria. Case Rep Hematol 2021;2021:6619177. [PMID: 34306774 DOI: 10.1155/2021/6619177] [Reference Citation Analysis]
48 Garred P, Tenner AJ, Mollnes TE. Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics. Pharmacol Rev 2021;73:792-827. [PMID: 33687995 DOI: 10.1124/pharmrev.120.000072] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
49 Gaut JP, Liapis H. Acute kidney injury pathology and pathophysiology: a retrospective review. Clin Kidney J 2021;14:526-36. [PMID: 33623675 DOI: 10.1093/ckj/sfaa142] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
50 Hoevenaar M, Goossens D, Roorda J. Angiotensin-converting enzyme 2, the complement system, the kallikrein-kinin system, type-2 diabetes, interleukin-6, and their interactions regarding the complex COVID-19 pathophysiological crossroads. J Renin Angiotensin Aldosterone Syst 2020;21:1470320320979097. [PMID: 33283602 DOI: 10.1177/1470320320979097] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 Lucchini G, Furness C, Lawson S, Gibson B, Wynn R, Slatter M, Shillitoe B, James B, Carpenter B, Hough R, Amrolia P, de la Fuente J; UK and Ireland Paediatric BMT Group. COVID-19 infection in paediatric recipients of allogeneic stem cell transplantation: the UK experience. Br J Haematol 2021;194:e74-7. [PMID: 34132400 DOI: 10.1111/bjh.17547] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Bilge A, Karasoy İ, Neziroğlu E, Güner Y. Upper extremity arterial thromboembolism in a patient with severe COVID-19 pneumonia: A case report. Jt Dis Relat Surg 2021;32:551-5. [PMID: 34145839 DOI: 10.52312/jdrs.2021.82766] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Lacout C, Rogez J, Orvain C, Nicot C, Rony L, Julien H, Urbanski G. A new diagnosis of systemic capillary leak syndrome in a patient with COVID-19. Rheumatology (Oxford) 2021;60:e19-20. [PMID: 32940700 DOI: 10.1093/rheumatology/keaa606] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
54 El Sissy C, Saldman A, Zanetta G, Martins PV, Poulain C, Cauchois R, Kaplanski G, Venetz JP, Bobot M, Dobosziewicz H, Daniel L, Koubi M, Sadallah S, Rotman S, Mousson C, Pascual M, Frémeaux-Bacchi V, Fakhouri F. COVID-19 as a potential trigger of complement-mediated atypical HUS. Blood 2021;138:1777-82. [PMID: 34482396 DOI: 10.1182/blood.2021012752] [Reference Citation Analysis]
55 Wessels I, Rolles B, Slusarenko AJ, Rink L. Zinc deficiency as a possible risk factor for increased susceptibility and severe progression of Corona Virus Disease 19. Br J Nutr 2021;:1-19. [PMID: 33641685 DOI: 10.1017/S0007114521000738] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
56 Boero E, Schreiber A, Rovida S, Vetrugno L, Blaivas M. The role of lung ultrasonography in COVID-19 disease management. J Am Coll Emerg Physicians Open 2020. [PMID: 32838389 DOI: 10.1002/emp2.12194] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
57 Campbell CM, Guha A, Haque T, Neilan TG, Addison D. Repurposing Immunomodulatory Therapies against Coronavirus Disease 2019 (COVID-19) in the Era of Cardiac Vigilance: A Systematic Review. J Clin Med 2020;9:E2935. [PMID: 32932930 DOI: 10.3390/jcm9092935] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
58 Carbone F, Montecucco F, Twickler M. SARS-CoV-2: What is known and what there is to know-Focus on coagulation and lipids. Eur J Clin Invest 2020;50:e13311. [PMID: 32511751 DOI: 10.1111/eci.13311] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
59 Reisi-Vanani V, Lorigooini Z, Dayani MA, Mardani M, Rahmani F. Massive intraperitoneal hemorrhage in patients with COVID-19: a case series. J Thromb Thrombolysis 2021;52:338-44. [PMID: 33909261 DOI: 10.1007/s11239-021-02447-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Java A, Apicelli AJ, Liszewski MK, Coler-Reilly A, Atkinson JP, Kim AH, Kulkarni HS. The complement system in COVID-19: friend and foe? JCI Insight 2020;5:140711. [PMID: 32554923 DOI: 10.1172/jci.insight.140711] [Cited by in Crossref: 100] [Cited by in F6Publishing: 87] [Article Influence: 50.0] [Reference Citation Analysis]
61 Gascon P, Briantais A, Bertrand E, Ramtohul P, Comet A, Beylerian M, Sauvan L, Swiader L, Durand JM, Denis D. Covid-19-Associated Retinopathy: A Case Report. Ocul Immunol Inflamm 2020;28:1293-7. [PMID: 33021856 DOI: 10.1080/09273948.2020.1825751] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 13.0] [Reference Citation Analysis]
62 Szegedi I, Orbán-Kálmándi R, Csiba L, Bagoly Z. Stroke as a Potential Complication of COVID-19-Associated Coagulopathy: A Narrative and Systematic Review of the Literature. J Clin Med 2020;9:E3137. [PMID: 32998398 DOI: 10.3390/jcm9103137] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
63 Pourdowlat G, Naderi Z, Seif F, Mansouri D, Raji H. Acrocyanosis and digital necrosis are associated with poor prognosis in COVID-19. Clin Case Rep 2020;8:2769-72. [PMID: 33363819 DOI: 10.1002/ccr3.3276] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
64 Onorato D, Pucci M, Carpene G, Henry BM, Sanchis-Gomar F, Lippi G. Protective Effects of Statins Administration in European and North American Patients Infected with COVID-19: A Meta-Analysis. Semin Thromb Hemost 2021;47:392-9. [PMID: 33482680 DOI: 10.1055/s-0040-1722307] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
65 Lange A, Lange J, Jaskuła E. Cytokine Overproduction and Immune System Dysregulation in alloHSCT and COVID-19 Patients. Front Immunol 2021;12:658896. [PMID: 34149697 DOI: 10.3389/fimmu.2021.658896] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Sukumar S, Gavriilaki E, Chaturvedi S. Updates on thrombotic thrombocytopenic purpura: Recent developments in pathogenesis, treatment and survivorship. Thrombosis Update 2021;5:100062. [DOI: 10.1016/j.tru.2021.100062] [Reference Citation Analysis]
67 Tampaki A, Gavriilaki E, Varelas C, Anagnostopoulos A, Vlachaki E. Complement in sickle cell disease and targeted therapy: I know one thing, that I know nothing. Blood Rev 2021;48:100805. [PMID: 33504459 DOI: 10.1016/j.blre.2021.100805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
68 Gunduz ZB. Venous sinus thrombosis during COVID-19 infection in pregnancy: a case report. Sao Paulo Med J 2021;139:190-5. [PMID: 33605306 DOI: 10.1590/1516-3180.2020.0659.R1.08122020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
69 Ulloa JH, Figueroa V, Cifuentes JS, Pinto P, Lurie F. The Impact of COVID-19 on Vascular Surgery Practice: A Systematic Review. Vasc Endovascular Surg 2021;55:601-11. [PMID: 33657926 DOI: 10.1177/1538574421998212] [Reference Citation Analysis]
70 Dag Seker E, Erbahceci Timur IE. COVID-19: more than a respiratory virus, an optical coherence tomography study. Int Ophthalmol 2021. [PMID: 34318370 DOI: 10.1007/s10792-021-01952-5] [Reference Citation Analysis]
71 Jacob CO. On the genetics and immunopathogenesis of COVID-19. Clin Immunol 2020;220:108591. [PMID: 32920210 DOI: 10.1016/j.clim.2020.108591] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
72 Cetinkaya T, Kurt MM, Akpolat C. Assessment of Retinal Neurodegeneration and Choroidal Thickness in COVID-19 Patients Using Swept-Source OCT Technology. Klin Monbl Augenheilkd 2021. [PMID: 33853186 DOI: 10.1055/a-1340-0066] [Reference Citation Analysis]
73 Erogul O, Gobeka HH, Dogan M, Akdogan M, Balci A, Kasikci M. Retinal microvascular morphology versus COVID-19: What to anticipate? Photodiagnosis Photodyn Ther 2022;:102920. [PMID: 35597442 DOI: 10.1016/j.pdpdt.2022.102920] [Reference Citation Analysis]
74 Razeghi Jahromi S, Moradi Tabriz H, Togha M, Ariyanfar S, Ghorbani Z, Naeeni S, Haghighi S, Jazayeri A, Montazeri M, Talebpour M, Ashraf H, Ebrahimi M, Hekmatdoost A, Jafari E. The correlation between serum selenium, zinc, and COVID-19 severity: an observational study. BMC Infect Dis 2021;21:899. [PMID: 34479494 DOI: 10.1186/s12879-021-06617-3] [Reference Citation Analysis]
75 Yener AÜ. COVID-19 and the Eye: Ocular Manifestations, Treatment and Protection Measures. Ocul Immunol Inflamm 2021;:1-9. [PMID: 34648417 DOI: 10.1080/09273948.2021.1977829] [Reference Citation Analysis]
76 Perea Polak A, Romero Madrid B, García Ocaña PP, Lomeña Alvarez G, Martínez Pilar L, Gómez-Moyano E. Complement-mediated thrombogenic vasculopathy in COVID-19. Int J Dermatol 2021;60:229-32. [PMID: 33259066 DOI: 10.1111/ijd.15267] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
77 Gavriilaki E, Anyfanti P, Gavriilaki M, Lazaridis A, Douma S, Gkaliagkousi E. Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses. Curr Hypertens Rep 2020;22:63. [PMID: 32852642 DOI: 10.1007/s11906-020-01078-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 21.0] [Reference Citation Analysis]
78 Henry BM, Benoit SW, de Oliveira MHS, Lippi G, Favaloro EJ, Benoit JL. ADAMTS13 activity to von Willebrand factor antigen ratio predicts acute kidney injury in patients with COVID-19: Evidence of SARS-CoV-2 induced secondary thrombotic microangiopathy. Int J Lab Hematol 2021;43 Suppl 1:129-36. [PMID: 33270980 DOI: 10.1111/ijlh.13415] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
79 Satyam A, Tsokos MG, Brook OR, Hecht JL, Moulton VR, Tsokos GC. Activation of classical and alternative complement pathways in the pathogenesis of lung injury in COVID-19. Clin Immunol 2021;226:108716. [PMID: 33774179 DOI: 10.1016/j.clim.2021.108716] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
80 Mennuni MG, Renda G, Grisafi L, Rognoni A, Colombo C, Lio V, Foglietta M, Petrilli I, Pirisi M, Spinoni E, Azzolina D, Hayden E, Aimaretti G, Avanzi GC, Bellan M, Cantaluppi V, Capponi A, Castello LM, D'Ardes D, Corte FD, Gallina S, Krengli M, Malerba M, Pierdomenico SD, Savoia P, Zeppegno P, Sainaghi PP, Cipollone F, Patti G; COVID-UPO Clinical Team. Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19. J Thromb Thrombolysis 2021. [PMID: 33649979 DOI: 10.1007/s11239-021-02401-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
81 Shehi E, Chilimuri S, Shin D, Patel M, Ali N, Niazi M. Microthrombi in skin biopsy of a patient with COVID-19. JAAD Case Rep 2020;6:1327-9. [PMID: 33072831 DOI: 10.1016/j.jdcr.2020.10.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
82 Peymani P, Dehesh T, Aligolighasemabadi F, Sadeghdoust M, Kotfis K, Ahmadi M, Mehrbod P, Iranpour P, Dastghaib S, Nasimian A, Ravandi A, Kidane B, Ahmed N, Sharma P, Shojaei S, Bagheri Lankarani K, Madej A, Rezaei N, Madrakian T, Los MJ, Labouta HI, Mokarram P, Ghavami S. Statins in patients with COVID-19: a retrospective cohort study in Iranian COVID-19 patients. Transl Med Commun 2021;6:3. [PMID: 33521322 DOI: 10.1186/s41231-021-00082-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
83 [DOI: 10.1101/2020.06.22.20131573] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
84 Iba T, Levy JH, Connors JM, Warkentin TE, Thachil J, Levi M. The unique characteristics of COVID-19 coagulopathy. Crit Care. 2020;24:360. [PMID: 32552865 DOI: 10.1186/s13054-020-03077-0] [Cited by in Crossref: 146] [Cited by in F6Publishing: 131] [Article Influence: 73.0] [Reference Citation Analysis]
85 Sánchez-Tena MÁ, Martinez-Perez C, Villa-Collar C, Alvarez-Peregrina C. Impact of COVID-19 at the Ocular Level: A Citation Network Study. J Clin Med 2021;10:1340. [PMID: 33804977 DOI: 10.3390/jcm10071340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Holter JC, Pischke SE, de Boer E, Lind A, Jenum S, Holten AR, Tonby K, Barratt-Due A, Sokolova M, Schjalm C, Chaban V, Kolderup A, Tran T, Tollefsrud Gjølberg T, Skeie LG, Hesstvedt L, Ormåsen V, Fevang B, Austad C, Müller KE, Fladeby C, Holberg-Petersen M, Halvorsen B, Müller F, Aukrust P, Dudman S, Ueland T, Andersen JT, Lund-Johansen F, Heggelund L, Dyrhol-Riise AM, Mollnes TE. Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients. Proc Natl Acad Sci U S A 2020;117:25018-25. [PMID: 32943538 DOI: 10.1073/pnas.2010540117] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 37.5] [Reference Citation Analysis]
87 Kulkarni A, Nasa P, Polumuru S, Singh A. Thrombotic Microangiopathy Causing Acute Kidney Injury in a COVID-19 Patient. Indian J Nephrol 2021;31:559-61. [PMID: 35068764 DOI: 10.4103/ijn.IJN_374_20] [Reference Citation Analysis]
88 Gavriilaki E, Asteris PG, Touloumenidou T, Koravou EE, Koutra M, Papayanni PG, Karali V, Papalexandri A, Varelas C, Chatzopoulou F, Chatzidimitriou M, Chatzidimitriou D, Veleni A, Grigoriadis S, Rapti E, Chloros D, Kioumis I, Kaimakamis E, Bitzani M, Boumpas D, Tsantes A, Sotiropoulos D, Sakellari I, Kalantzis IG, Parastatidis ST, Koopialipoor M, Cavaleri L, Armaghani DJ, Papadopoulou A, Brodsky RA, Kokoris S, Anagnostopoulos A. Genetic justification of severe COVID-19 using a rigorous algorithm. Clin Immunol 2021;226:108726. [PMID: 33845193 DOI: 10.1016/j.clim.2021.108726] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
89 Cetinkaya T, Kurt MM, Akpolat C. Analysis of swept-source optical coherence tomography angiography measurement alterations in adult patients recovered from COVID-19. Clin Exp Optom 2021;:1-5. [PMID: 34875203 DOI: 10.1080/08164622.2021.1999770] [Reference Citation Analysis]
90 Mat O, Ghisdal L, Massart A, Aydin S, Goubella A, Blankoff N, Gankam F, Debelle F, Mat Q. Kidney Thrombotic Microangiopathy After COVID-19 Associated With C3 Gene Mutation. Kidney Int Rep 2021;6:1732-7. [PMID: 33851069 DOI: 10.1016/j.ekir.2021.03.897] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
91 Chatzidimitriou M, Chatzopoulou F, Gavriilaki E, Chatzivasileiou P, Rousis D, Meletis G, Chatzidimitriou D. Repeated Negative Serological Testing in Otherwise Healthy Patients With Coronavirus Disease 2019. J Infect Dis 2021;223:924-6. [PMID: 32726440 DOI: 10.1093/infdis/jiaa453] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Francischetti IMB, Toomer K, Zhang Y, Jani J, Siddiqui Z, Brotman DJ, Hooper JE, Kickler TS. Upregulation of pulmonary tissue factor, loss of thrombomodulin and immunothrombosis in SARS-CoV-2 infection. EClinicalMedicine 2021;39:101069. [PMID: 34377969 DOI: 10.1016/j.eclinm.2021.101069] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
93 Jespersen Nizamic T, Huang Y, Alnimri M, Cheng M, Chen LX, Jen KY. COVID-19 Manifesting as Renal Allograft Dysfunction, Acute Pancreatitis, and Thrombotic Microangiopathy: A Case Report. Transplant Proc. 2020;. [PMID: 33436168 DOI: 10.1016/j.transproceed.2020.10.048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
94 Shimmel A, Shaikhouni S, Mariani L. Current Understanding of Clinical Manifestations of COVID-19 in Glomerular Disease. Glomerular Dis 2021;1:250-64. [DOI: 10.1159/000518276] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Hernández-Huerta MT, Pérez-Santiago AD, Pérez-Campos Mayoral L, Sánchez Navarro LM, Rodal Canales FJ, Majluf-Cruz A, Matias-Cervantes CA, Pérez-Campos Mayoral E, Romero Díaz C, Mayoral-Andrade G, Martínez Cruz M, Luna Ángel J, Pérez-Campos E. Mechanisms of Immunothrombosis by SARS-CoV-2. Biomolecules 2021;11:1550. [PMID: 34827548 DOI: 10.3390/biom11111550] [Reference Citation Analysis]
96 Magnani HN. Rationale for the Role of Heparin and Related GAG Antithrombotics in COVID-19 Infection. Clin Appl Thromb Hemost 2021;27:1076029620977702. [PMID: 33539214 DOI: 10.1177/1076029620977702] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
97 Martinelli N, Montagnana M, Pizzolo F, Friso S, Salvagno GL, Forni GL, Gianesin B, Morandi M, Lunardi C, Lippi G, Polati E, Olivieri O, De Franceschi L. A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19. Thromb Res 2020;193:170-2. [PMID: 32707276 DOI: 10.1016/j.thromres.2020.07.034] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 14.5] [Reference Citation Analysis]
98 Asteris PG, Gavriilaki E, Touloumenidou T, Koravou E, Koutra M, Papayanni PG, Pouleres A, Karali V, Lemonis ME, Mamou A, Skentou AD, Papalexandri A, Varelas C, Chatzopoulou F, Chatzidimitriou M, Chatzidimitriou D, Veleni A, Rapti E, Kioumis I, Kaimakamis E, Bitzani M, Boumpas D, Tsantes A, Sotiropoulos D, Papadopoulou A, Kalantzis IG, Vallianatou LA, Armaghani DJ, Cavaleri L, Gandomi AH, Hajihassani M, Hasanipanah M, Koopialipoor M, Lourenço PB, Samui P, Zhou J, Sakellari I, Valsami S, Politou M, Kokoris S, Anagnostopoulos A. Genetic prediction of ICU hospitalization and mortality in COVID‐19 patients using artificial neural networks. J Cellular Molecular Medi. [DOI: 10.1111/jcmm.17098] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
99 Vitiello A, La Porta R, D'Aiuto V, Ferrara F. Pharmacological approach for the reduction of inflammatory and prothrombotic hyperactive state in COVID-19 positive patients by acting on complement cascade. Hum Immunol 2021;82:264-9. [PMID: 33632561 DOI: 10.1016/j.humimm.2021.01.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
100 Acharya Y, Alameer A, Calpin G, Alkhattab M, Sultan S. A comprehensive review of vascular complications in COVID-19. J Thromb Thrombolysis 2021. [PMID: 34724155 DOI: 10.1007/s11239-021-02593-2] [Reference Citation Analysis]
101 Vinciguerra M, Romiti S, Sangiorgi GM, Rose D, Miraldi F, Greco E. SARS-CoV-2 and Atherosclerosis: Should COVID-19 Be Recognized as a New Predisposing Cardiovascular Risk Factor? J Cardiovasc Dev Dis 2021;8:130. [PMID: 34677199 DOI: 10.3390/jcdd8100130] [Reference Citation Analysis]
102 Kulkarni A, Nasa P, Polumuru S, Singh A. Thrombotic Microangiopathy Causing Acute Kidney Injury in a COVID-19 Patient. Indian J Nephrol 2021;31:559-61. [PMID: 35068764 DOI: 10.4103/ijn.IJN_374_20] [Reference Citation Analysis]
103 Mahjoub A, Dlensi A, Romdhane A, Ben Abdesslem N, Mahjoub A, Bachraoui C, Mahjoub H, Ghorbel M, Knani L, Krifa F. [Bilateral central serous chorioretinopathy post-COVID-19]. J Fr Ophtalmol 2021;44:1484-90. [PMID: 34756744 DOI: 10.1016/j.jfo.2021.10.001] [Reference Citation Analysis]
104 Zarkesh K, Entezar-Almahdi E, Ghasemiyeh P, Akbarian M, Bahmani M, Roudaki S, Fazlinejad R, Mohammadi-Samani S, Firouzabadi N, Hosseini M, Farjadian F. Drug-based therapeutic strategies for COVID-19-infected patients and their challenges. Future Microbiol 2021;16:1415-51. [PMID: 34812049 DOI: 10.2217/fmb-2021-0116] [Reference Citation Analysis]
105 Muniangi-Muhitu H, Akalestou E, Salem V, Misra S, Oliver NS, Rutter GA. Covid-19 and Diabetes: A Complex Bidirectional Relationship. Front Endocrinol (Lausanne). 2020;11:582936. [PMID: 33133024 DOI: 10.3389/fendo.2020.582936] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
106 B DJ. Historical aspects and current understanding of the connections and implications of viruses and diabetes: A narrative review. Clinical Epidemiology and Global Health 2022;16:101110. [DOI: 10.1016/j.cegh.2022.101110] [Reference Citation Analysis]
107 Chen-Goodspeed A, Idowu M. COVID-19 Presentation in Patients with Sickle Cell Disease: A Case Series. Am J Case Rep 2021;22:e931758. [PMID: 33941758 DOI: 10.12659/AJCR.931758] [Reference Citation Analysis]
108 Talasaz AH, Sadeghipour P, Aghakouchakzadeh M, Kakavand H, Ariannejad H, Connors JM, Hunt BJ, Berger JS, Van Tassell BW, Middeldorp S, Piazza G, Weitz JI, Cushman M, Lip GYH, Goldhaber SZ, Bikdeli B. Use of novel antithrombotic agents for COVID-19: Systematic summary of ongoing randomized controlled trials. J Thromb Haemost 2021. [PMID: 34538017 DOI: 10.1111/jth.15533] [Reference Citation Analysis]
109 Karim S, Islam A, Rafiq S, Laher I. The COVID-19 Pandemic: Disproportionate Thrombotic Tendency and Management Recommendations. Trop Med Infect Dis 2021;6:26. [PMID: 33670475 DOI: 10.3390/tropicalmed6010026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
110 Plotz B, Castillo R, Melamed J, Magro C, Rosenthal P, Belmont HM. Focal small bowel thrombotic microvascular injury in COVID-19 mediated by the lectin complement pathway masquerading as lupus enteritis. Rheumatology (Oxford) 2021;60:e61-3. [PMID: 33147605 DOI: 10.1093/rheumatology/keaa627] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Fernández-pérez G, Oñate Miranda M, Fernández-rodríguez P, Velasco Casares M, Corral de la Calle M, Franco López Á, Díez Blanco M, Oñate Cuchat J. SARS-CoV-2: what it is, how it acts, and how it manifests in imaging studies. Radiología (English Edition) 2021;63:115-26. [DOI: 10.1016/j.rxeng.2020.10.006] [Reference Citation Analysis]
112 Lee KCH, Sewa DW, Phua GC. Potential role of statins in COVID-19. Int J Infect Dis 2020;96:615-7. [PMID: 32502659 DOI: 10.1016/j.ijid.2020.05.115] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 18.5] [Reference Citation Analysis]
113 Kurian CJ, French Z, Kukulich P, Lankiewicz M, Ghimire S, Maarouf OH, Rizk S, Rhoades R. Case series: coronavirus disease 2019 infection as a precipitant of atypical hemolytic uremic syndrome: two case reports. J Med Case Rep 2021;15:587. [PMID: 34903272 DOI: 10.1186/s13256-021-03144-2] [Reference Citation Analysis]
114 Delshad M, Safaroghli-Azar A, Pourbagheri-Sigaroodi A, Poopak B, Shokouhi S, Bashash D. Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity. Int Immunopharmacol 2021;99:107995. [PMID: 34304001 DOI: 10.1016/j.intimp.2021.107995] [Reference Citation Analysis]
115 Goswami J, Macarthur TA, Sridharan M, Tange J, Kirmse AJ, Lundell KA, Chen D, Auton MT, Chon TY, Hurt RT, Salonen BR, Ganesh R, Erben YM, Marquez CP, Dong J, Kozar RA, Heller SF, Loomis EA, Johnstone AL, Bailey KR, Spears GM, Park MS. Biomarkers of thromboinflammation correlate to COVID-19 infection and admission status in emergency department patients. Thrombosis Update 2021;5:100090. [DOI: 10.1016/j.tru.2021.100090] [Reference Citation Analysis]